Ryzneuta: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

21 March 2024

19 March 2024

  • curprev 23:0823:08, 19 March 2024‎ Kosar Doraghi talk contribs‎ 10,759 bytes +8‎ No edit summary
  • curprev 23:0723:07, 19 March 2024‎ Kosar Doraghi talk contribs‎ 10,751 bytes +10,751‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.com]] |genericName=RYZNEUTA -Efbemalenograstim alfa-vuxw |aOrAn=a |drugClass=leukocyte growth factor |indicationType=treatment |indication=and decrease the incidence of infection, as manifested by [febrile neutropenia], in adult patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia |h..."
Retrieved from "https://www.wikidoc.org/index.php/Ryzneuta"